Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis

被引：1
作者：
Benesova, Yvonne [1 ,2 ]
机构：
[1] Univ Hosp Brno, Dept Neurol, Brno, Czech Republic
[2] Masaryk Univ Neurol, Fac Med, Brno, Czech Republic
来源：
MULTIPLE SCLEROSIS JOURNAL | 2009年 / 15卷 / 11期
关键词：
BLOOD; MMP-9;
D O I：
10.1177/1352458509348421
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：1374 / 1375
页数：2
相关论文
共 8 条
[1]   Serum MMP-2 and MMP-9 are elevated in different multiple sclerosis subtypes [J].
Avolio, C ;
Ruggieri, M ;
Giuliani, F ;
Liuzzi, GM ;
Leante, R ;
Riccio, P ;
Livrea, P ;
Trojano, M .
JOURNAL OF NEUROIMMUNOLOGY, 2003, 136 (1-2) :46-53
[2]   Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies (vol 13, pg 561, 2007) [J].
Fainardi, E. ;
Castellazzi, M. ;
Bellini, T. ;
Dallocchio, F. .
MULTIPLE SCLEROSIS, 2007, 13 (05) :691-692
[3]   Impact of blood sampling on the circulating matrix metalloproteinases 1, 2, 3, 7, 8, and 9 [J].
Jung, Klaus ;
Klotzek, Silke ;
Stephan, Carsten ;
Mannell, Ferdinando ;
Lein, Michael .
CLINICAL CHEMISTRY, 2008, 54 (04) :772-774
[4]   Intrathecal synthesis of matrix metalloproteinase-9 in patients with multiple sclerosis: implication for pathogenesis [J].
Liuzzi, GM ;
Trojano, M ;
Fanelli, M ;
Avolio, C ;
Fasano, A ;
Livrea, P ;
Riccio, P .
MULTIPLE SCLEROSIS, 2002, 8 (03) :222-228
[5]   Heparin affects matrix metalloproteinases and tissue inhibitors of metalloproteinases circulating in peripheral blood [J].
Mannello, Ferdinando ;
Jung, Klaus ;
Tonti, Gaetana A. ;
Canestrari, Franco .
CLINICAL BIOCHEMISTRY, 2008, 41 (18) :1466-1473
[6]   Concentrations of circulating gelatinases (Matrix metalloproteinase-2 and-9) are dependent on the conditions of blood collection [J].
Meisser, A ;
Cohen, M ;
Bischof, P .
CLINICAL CHEMISTRY, 2005, 51 (01) :274-276
[7]   Serum MMP-9 and TIMP-1 levels are related to MRI activity in relapsing multiple sclerosis [J].
Waubant, E ;
Goodkin, DE ;
Gee, L ;
Bacchetti, P ;
Sloan, R ;
Stewart, T ;
Andersson, PB ;
Stabler, G ;
Miller, K .
NEUROLOGY, 1999, 53 (07) :1397-1401
[8]   IFNβ lowers MMP-9/TIMP-1 ratio, which predicts new enhancing lesions in patients with SPMS [J].
Waubant, E ;
Goodkin, D ;
Bostrom, A ;
Bacchetti, P ;
Hietpas, J ;
Lindberg, R ;
Leppert, D .
NEUROLOGY, 2003, 60 (01) :52-57
1